Researchers to test first gene therapy For Alzheimer's patients
Tuesday, November 17, 2009 - 14:21
in Health & Medicine
Mount Sinai School of Medicine is one of 12 sites nationwide participating in the first Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease. The study is the first multicenter neurosurgical intervention in Alzheimer's research in the U.S.